Germany's new pharmacy law sparks fierce debate over funding and standards
A new law to support pharmacies in Germany is under discussion in the Bundestag's Health Committee. The Pharmacy Supply Development Act (ApoVWG) aims to address long-standing concerns about declining pharmacy numbers and funding pressures. Industry leaders have shared mixed reactions to the proposed changes.
Thomas Preis, head of the German Pharmacists' Association (ABDA), welcomed plans to raise the fixed fee for pharmacies through an accompanying regulation. He highlighted a steady drop in pharmacy numbers over the past 13 years and urged quick action to prevent further closures. Preis also warned against moves to 'deprofessionalise' the sector, such as allowing pharmacies to operate without qualified pharmacists or on-site labs.
Markus Grunenberg of the National Association of Statutory Health Insurance Funds (GKV-Spitzenverband) raised concerns about the financial impact. He estimated that increasing the fixed fee would cost taxpayers around €1 billion. Meanwhile, Dr. Stefan Hartmann of the BVDAK called for a different approach to how prescription compounding is reimbursed.
Other voices in the debate included Ulrich Langenberg of the German Medical Association (BÄK), who opposed plans to sell prescription-only medications over the counter. Thomas Porstner, representing the Phagro wholesale association, pushed for stricter inspections of logistics providers to ensure proper storage and transport of medicines. Bork Bretthauer of Pro Generika praised the reliable supply of biosimilars but demanded a ban on exclusivity deals that could limit competition.
Anja Zierath of the BVpta rejected proposals for pharmacy representation without additional training. She argued that further qualifications were necessary to maintain professional standards.
The Health Committee's discussions reflect deep divisions over how to secure the future of Germany's pharmacies. While some back higher fees and stricter regulations, others warn of rising costs and lower standards. The outcome of the debate will shape pharmacy operations and patient access to medicines in the coming years.
Read also:
- India's Agriculture Minister Reviews Sector Progress Amid Heavy Rains, Crop Areas Up
- Over 1.7M in Baden-Württemberg at Poverty Risk, Emmendingen's Housing Crisis Urgent
- Life Expectancy Soars, But Youth Suicide and Substance Abuse Pose Concern
- Cyprus, Kuwait Strengthen Strategic Partnership with Upcoming Ministerial Meeting
